BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6193764)

  • 1. CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis.
    Koslow SH; Maas JW; Bowden CL; Davis JM; Hanin I; Javaid J
    Arch Gen Psychiatry; 1983 Sep; 40(9):999-1010. PubMed ID: 6193764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls.
    Davis JM; Koslow SH; Gibbons RD; Maas JW; Bowden CL; Casper R; Hanin I; Javaid JI; Chang SS; Stokes PE
    Arch Gen Psychiatry; 1988 Aug; 45(8):705-17. PubMed ID: 2456047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH.
    Grossman F; Potter WZ
    Psychiatry Res; 1999 Jul; 87(1):21-7. PubMed ID: 10512151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biogenic amine metabolites in delusional (psychotic) depression and melancholia subtypes of major depression.
    Lykouras L; Markianos M; Hatzimanolis J; Malliaras D; Stefanis C
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1261-71. PubMed ID: 7532316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF monoamine metabolites in mania.
    Swann AC; Secunda S; Davis JM; Robins E; Hanin I; Koslow SH; Maas JW
    Am J Psychiatry; 1983 Apr; 140(4):396-400. PubMed ID: 6188381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
    Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E
    Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity.
    Stokes PE; Maas JW; Davis JM; Koslow SH; Casper RC; Stoll PM
    Am J Psychiatry; 1987 Jul; 144(7):868-72. PubMed ID: 2440319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of amine metabolites in depressed patients. Relationship to suicidal behavior.
    Secunda SK; Cross CK; Koslow S; Katz MM; Kocsis JH; Maas JW
    Ann N Y Acad Sci; 1986; 487():231-42. PubMed ID: 2436536
    [No Abstract]   [Full Text] [Related]  

  • 11. Catecholamine metabolism and disposition in healthy and depressed subjects.
    Maas JW; Koslow SH; Davis J; Katz M; Frazer A; Bowden CL; Berman N; Gibbons R; Stokes P; Landis DH
    Arch Gen Psychiatry; 1987 Apr; 44(4):337-44. PubMed ID: 3566456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome.
    Swann AC; Koslow SH; Katz MM; Maas JW; Javaid J; Secunda SK; Robins E
    Arch Gen Psychiatry; 1987 Apr; 44(4):345-54. PubMed ID: 2436590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209
    [No Abstract]   [Full Text] [Related]  

  • 15. CSF-amine metabolites in depression, dementia and in controls.
    Gjerris A; Werdelin L; Gjerris F; Sørensen PS; Rafaelsen OJ; Alling C
    Acta Psychiatr Scand; 1987 Jun; 75(6):619-28. PubMed ID: 2441573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder.
    Young LT; Warsh JJ; Kish SJ; Shannak K; Hornykeiwicz O
    Biol Psychiatry; 1994 Jan; 35(2):121-7. PubMed ID: 7513191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.
    Redmond DE; Katz MM; Maas JW; Swann A; Casper R; Davis JM
    Arch Gen Psychiatry; 1986 Oct; 43(10):938-47. PubMed ID: 2428328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine metabolite levels in rat CSF: kinetic studies.
    Scheinin H; Scheinin M
    Pharmacol Toxicol; 1987 Sep; 61(3):167-71. PubMed ID: 2446306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biogenic amines and affective disorders.
    Schildkraut JJ
    Annu Rev Med; 1974; 25(0):333-48. PubMed ID: 4368455
    [No Abstract]   [Full Text] [Related]  

  • 20. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
    Maas JW; Koslow SH; Katz MM; Bowden CL; Gibbons RL; Stokes PE; Robins E; Davis JM
    Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.